![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Ufer Mike
Publisher: Adis International
ISSN: 0312-5963
Source: Clinical Pharmacokinetics, Vol.44, Iss.12, 2005-01, pp. : 1227-1246
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Vitamin K antagonists associated with arterial calcinosis
Reactions Weekly, Vol. 1, Iss. 1258, 2009-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
QOL effect of treatment duration with vitamin K antagonists
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 430, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Acenocoumarol/miconazole/phenprocoumon interaction: Loss of coagulation control: 4 case reports
Reactions Weekly, Vol. 1, Iss. 1333, 2011-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Floyd Christopher N. Passacquale Gabriella Ferro Albert
Clinical Pharmacokinetics, Vol. 51, Iss. 7, 2012-07 ,pp. :